Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 15Phase 1/2 5Phase NA 4Phase 3 3Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1Breast 1

Conditions

Neoplasm Metastasis 4Neoplasms 3Carcinoma, Renal Cell 3Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Recurrence 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Radiosurgery 23Magnetic Resonance Spectroscopy 13Radiotherapy 9Cryosurgery 9Blood Specimen Collection 9Standard of Care 8Surveys and Questionnaires 7Educational Status 7Surgical Procedures, Operative 6Drug Therapy 6Radiotherapy, Intensity-Modulated 5Palliative Care 5Methods 5Radiofrequency Ablation 4Practice Guidelines as Topic 4Everolimus 4Early Intervention, Educational 4Interviews as Topic 3Exercise Therapy 3Cryotherapy 3Androgen Antagonists 3Zoledronic Acid 2Videotape Recording 2Trastuzumab 2Radiation 2Physical Therapy Modalities 2Patient Navigation 2Misoprostol 2Manual Lymphatic Drainage 2Liver Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Neoplasm Metastasis × Everolimus × Clear all
NCT01190241 2020-11-20

TSAP

Amsterdam UMC, location VUmc

Phase NA Terminated
45 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02109913 2019-10-14

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Amsterdam UMC, location VUmc

Phase NA Unknown
175 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01107509 2018-04-04

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

St. Joseph's Healthcare Hamilton

Phase NA Completed
20 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT02450175 2015-05-21

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Sinai Hospital of Baltimore

Phase NA Unknown
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡